Search Results for:
-
FIRST AIDS PATIENT GETS FIRST VIRAL-GENE VACCINE IN JUST-LAUNCHED
investigational new drug applicationBioWorld Today | Monday, June 19, 1995 -
TEVA FILES FOR FDA APPROVAL OF MULTIPLE SCLEROSIS DRUG
Thursday filed a new drug application (NDA) with the FDA for approval of Copaxone for multiple sclerosisBioWorld Today | Friday, June 16, 1995 -
COST, EFFECTS OF ADVERSE EVENT REPORTING REGULATIONS DETAILED BY
In 1994, DuPont Merck submitted 179 periodic new drug application safety reports, either annually or quarterly, for 170 products and 104 annual investigational new drug applications, producing a total of 283 periodic safety reportsBioWorld Today | Thursday, June 15, 1995 -
CYTOGEN SUBMITS NDA FOR DRUG TO BATTLE PAIN IN CANCER VICTIMS
The Princeton, N.J.-based company Tuesday filed a new drug application (NDA) for Quadramet, boosting the company's stock (NASDAQ:CYTO) 22.5 percentBioWorld Today | Wednesday, June 14, 1995 -
RIBOZYME, PARKE-DAVIS EXTEND OSTEOARTHRITIS COLLABORATION
Christoffersen said the collaborators identified a number of ribozymes that potentially could be taken forward, but he declined to discuss the status of the candidates or project timetables on the filing of an investigational new drug applicationBioWorld Today | Friday, June 9, 1995 -
NEXSTAR GETS DAUNOXOME APPROVAL IN SWEDEN PRIOR TO ODAC MEETING
NeXstar used the Phase III data to file an amended new drug application in JanuaryBioWorld Today | Wednesday, June 7, 1995 -
PATENT TERM EXTENSION RAISES LARGER ISSUES
Under the Hatch-Waxman amendments, pharmaceutical companies seeking to market pioneer drugs must first obtain FDA approval through the filing of a new drug application (NDABioWorld Today | Tuesday, May 30, 1995 -
PATENT PROTECTION EXTENDED UNDER INTERNATIONAL TREATY
drug application on or after June 8, 1995BioWorld Today | Friday, May 26, 1995 -
CBER'S ZOON PROMISES INDUSTRY MORE REGULATORY RELIEF
Instead of letting several people be in charge, the center will designate one official for a manufacturer to deal with on a particular issue, similar to the designated official in charge of a new drug application, Zoon saidBioWorld Today | Wednesday, May 24, 1995 -
SCHWARZ LANDS CYTEL, CYLEXIN FOR FIRST BIOTECH COLLABORATION
The deal, including clinical developments costs, is worth about $70 million to Cytel assuming Cylexin is brought to the new drug application stage in the initial indication of acute myocardial infarction, said Deborah Goode, the company's director of business developmentBioWorld Today | Friday, May 19, 1995 -
INTERNEURON RESPONDS TO FDA ON CONCERNS ABOUT ANTI-OBESITY DRUG
Three months ago, the FDA sent Interneuron, of Lexington, Mass., a non-approvable letter for its new drug application (NDA) for dexfenfluramineBioWorld Today | Wednesday, May 17, 1995 -
ISIS REPORTS ADVERSE EVENTS IN PHASE III CMV RETINITIS STUDY
new drug applicationBioWorld Today | Monday, May 15, 1995 -
OTHER NEWS TO NOTE
Endocon Inc., of South Walpole, Mass., and Apollo Genetics Inc., of Cambridge, Mass., filed an investigational new drug application with the FDA to begin Phase I trials of NeurestrolBioWorld Today | Monday, May 15, 1995 -
ACADEMY OF NEUROLOGY MEETING
Pediatric neurologist Larry Powe, who directs central nervous system clinical research at RPR in Collegeville, explained that registration dossiers submitted to European health authorities are the equivalent of new drug applications filed with the U.S. Food and Drug AdministrationBioWorld Today | Thursday, May 11, 1995 -
LIPOSOME CO. COMPLETES PUBLIC OFFERING THAT NETS $25M
The company has filed for approvals in 18 countries, has been granted approval in the U.K., and expects to file a new drug application in the U.SBioWorld Today | Monday, May 1, 1995 -
OTHER NEWS TO NOTE
drug application for Amlexanox, for aphthous ulcers. (c) 1997 American Health ConsultantsBioWorld Today | Monday, April 24, 1995 -
GUILFORD'S GLIADEL REDUCES LOCAL REGIONAL RECURRENCE OF BRAIN TUMORS
Craig Smith, president and CEO of Baltimore-based Guilford, said the company plans to submit a treatment investigational new drug (IND) application in the third quarter, and a new drug application (NDA) in the fourth quarter this yearBioWorld Today | Monday, April 24, 1995 -
ICN SPECIAL COMMITTEE CONCLUDES VIRAZOLE PROBE
A special committee of ICN Pharmaceuticals Inc.'s board of directors cleared the company and its chairman and CEO, Milan Panic, of any inappropriate or misleading actions related to the FDA's rejection last November of a new drug application (NDA) for Virazole, an antiviral agent for hepatitis CBioWorld Today | Thursday, April 20, 1995 -
PHARMOS ISSUES 6M SHARES IN OCULON ACQUISITION
Pharmos submitted a new drug application for Lotemax (loteprednol etabonate) late in March, and plans to develop some related productsBioWorld Today | Friday, April 14, 1995 -
OTHER NEWS TO NOTE
Diatech Inc., of Londonderry, N.H., submitted an investigational new drug application to the FDA to begin clinical trials of Techtide, a technetium-99m labeled synthetic peptide, for detection of infections of unknown originBioWorld Today | Friday, April 14, 1995
Category
Current Filters
- xdrug application
Related Keywords
Categories
- x BioWorld Today (7434)
- x BioWorld Insight (561)
- x BioWorld International (479)
- x Bio Perspectives (114)
- x State of the Industry Report (45)
- x BioWorld Snapshots (16)
- x Top 25 Drug Report (12)
- x BioWorld Genomics Review (12)
- x Biotech Innovations (11)
- x RNAi Report (2)
- x Market-Leading Biotech Drugs (2)
- x Executive Compensation Report (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.